Saturday 17 October 2026 Export IOVA’s income statement to Excel — free account

Iovance Biotherapeutics, Inc.

Iovance Biotherapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $263.5 million, up 60.6% from fiscal 2024. In the quarter to June 2026, revenue grew 65.7%, EPS grew 66.7% and free cash flow grew 11.5%, each against the same quarter a year earlier.

13.58 1.14 −7.74%

Follow IOVA

Alert me

Market cap: $6.7B
P/E: 0.0×
Fwd P/E: −7.8×
Dividend yield: —
F-score: 4/9
Altman Z: −2.30
Beneish M: −2.46
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	0.00	0.00	0.00	0.00	+8 more quarters Free account
P/S ratio Full definition →	5.76	5.14	3.70	3.15
P/FCF ratio Full definition →	0.00	0.00	0.00	0.00
P/Operating CF Full definition →	(30.78)	(20.38)	(18.56)	(10.04)
P/B ratio Full definition →	2.54	2.04	1.40	1.12
Price to Tangible BV Full definition →	3.97	3.25	2.33	1.89
EV/Sales Full definition →	4.85	4.05	2.58	1.96
EV/EBITDA Full definition →	0.00	0.00	0.00	0.00
EV/Operating CF Full definition →	(5.97)	(4.27)	(2.25)	(1.52)
EV/FCF Full definition →	(5.32)	(3.79)	(2.02)	(1.39)
Quick Ratio Full definition →	3.74	3.05	2.74	2.92
Current Ratio Full definition →	4.35	3.60	3.20	3.41
Net Debt/EBITDA Full definition →	6.76	4.44	4.78	3.53
Debt/Assets Full definition →	0.00%	0.00%	0.00%	0.00%
Debt/Equity Full definition →	0.00	0.00	0.00	0.00
Asset Turnover Full definition →	0.36	0.30	0.29	0.26
Operating CF/Net income Full definition →	1.29	0.91	0.73	0.86
Capex/Depreciation Full definition →	(0.69)	(0.63)	(0.82)	(1.11)
Research and Development Expense of Revenue Full definition →	59.26%	87.48%	82.06%	111.44%
Selling, General and Administrative Expense of Revenue Full definition →	39.54%	54.53%	41.95%	51.23%
Intangible Assets out of Total Assets Full definition →	0.29	0.29	0.31	0.32
Share Based Compensation of Revenue Full definition →	11.81%	15.78%	13.62%	17.64%
Graham Net Nets Full definition →	0.15	0.18	0.23	0.29
Graham Number Full definition →	0.00	0.00	0.00	0.00
Earnings Yield Full definition →	(17.55%)	(27.07%)	(41.03%)	(55.30%)
Free Cash Flow Yield Full definition →	(15.83%)	(20.76%)	(34.47%)	(44.54%)
Revenue per Share Full definition →	0.22	0.17	0.24	0.19
Operating CF per Share Full definition →	(0.14)	(0.17)	(0.15)	(0.22)
Capex per Share Full definition →	(0.01)	(0.02)	(0.03)	(0.03)
Free Cash Flow per Share Full definition →	(0.15)	(0.19)	(0.17)	(0.25)
Cash per Share Full definition →	0.66	0.75	0.83	0.83
Shareholders Equity per Share Full definition →	1.64	1.72	1.95	1.93
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	1.64	1.72	1.95	1.93
Free Cash Flow Full definition →	(66.28)	(78.68)	(61.88)	(89.55)
Working Capital Full definition →	357.41	337.08	304.33	303.31
Capital Expenditures Full definition →	(5.44)	(6.61)	(9.32)	(10.84)
Net Current Asset Value Full definition →	284.77	262.59	228.10	226.43
EV/EBIT Full definition →	0.00	0.00	0.00	0.00
Capex to Sales Full definition →	0.05	0.09	0.11	0.16
Price to Operating Income Full definition →	0.00	0.00	0.00	0.00
Other line items
Average Receivables Full definition →	81.03	76.35	75.89	61.26
Average Payables Full definition →	29.11	32.97	24.83	31.46
Average Inventory Full definition →	52.71	61.96	51.60	45.14
Average Assets Full definition →	911.48	946.20	911.80	948.03
Average Common Equity Full definition →	717.26	744.81	704.49	737.87

Show all line items

Columns are period end dates

Stockrow Weekly